David V.

Englewood, FL

David’s Testimonial for COPD & Emphysema Treatment at the Lung Institute

Age: 66  |  Location: Englewood, FL  |  Condition: COPD, Emphysema

David V began sailing when he was ten years old, sailing across the Great Lakes and around the Caribbean. He loved being active and constantly moving. But, one day, David noticed it was becoming hard for him to breathe. His doctor diagnosed him with COPD and emphysema. David couldn’t work anymore, and he barely left the house. Soon, he felt depressed by the loss of the life he had before. Feeling as though he was shutting down, David knew it was time to make some decisions, so he called the Lung Institute.

After his cellular therapy, David started noticing improvements in his health in layers. First, he could walk better. Then, he could socialize more, and over time, David started sailing again. Two months after David’s treatment, he went to Toledo and sailed two times a week without any problems. As David says, “I got life again.”

If you or someone you love has COPD, emphysema, pulmonary fibrosis or another chronic lung disease and would like to learn more about cellular therapy, contact us at (800) 729-3065.

Are you a candidate? Call (800) 729-3065 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.